Deficient in Meeting the Exchange S Continued Listing Requirements

U.S. markets open in 9 hours 2 minutes

S&P Futures
Dow Futures
Nasdaq Futures
Russell 2000 Futures
Crude Oil
Gold
Silver
EUR/USD
10-Yr Bond
Vix
GBP/USD
USD/JPY
BTC-USD
CMC Crypto 200
FTSE 100
Nikkei 225

Timber Pharmaceuticals Announces Notification of NYSE American Continued Listing Deficiency

BASKING RIDGE, NJ, Aug. 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the "Company") (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that it had received a deficiency letter ("Letter") from NYSE American LLC ("NYSE American" or the "Exchange") stating that the Company is not in compliance with the continued listing standards as set forth in Section 1003(f)(v) of the NYSE American Company Guide ("Company Guide").

The Letter stated that because the Company's common stock had been trading for a low price per share for a substantial period of time, the Company was not in compliance with Section 1003(f)(v) of the Company Guide. The NYSE American staff determined that the Company's continued listing is predicated on it demonstrating sustained price improvement within a reasonable period of time or effecting a reverse stock split of its common stock, which the staff determined to be until February 23, 2023, which could be extended to the Company's next annual meeting of stockholders to be held in 2023. The Company intends to regain compliance with the NYSE American's continued listing standards by undertaking a measure or measures that are for the best interests of the Company and its stockholders.

The Letter has no immediate effect on the listing or trading of the Company's common stock and the common stock will continue to trade on the NYSE American under the symbol "TMBR". Additionally, the Letter does not result in the immediate delisting of the Company's common stock from the NYSE American. The Company's receipt of the Letter does not affect the Company's business, operations or reporting requirements with the Securities and Exchange Commission. The Company is actively engaged in discussions with the Exchange and is developing plans to regain compliance with the NYSE American's continued listing standards within the cure period.

About Timber Pharmaceuticals, Inc.

Timber Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases. The Company's investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing, and control) and safety profiles. The Company is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), and other sclerotic skin diseases. For more information, visit www.timberpharma.com.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the Company's ability to regain compliance with the NYSE American's continued listing standards, product development, clinical and regulatory timelines, market opportunity, competitive position, intellectual property rights, possible or assumed future results of operations, business strategies, potential growth opportunities and other statements that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management's current beliefs and assumptions.

These statements may be identified by the use of forward-looking expressions, including, but not limited to, "expect," "anticipate," "intend," "plan," "believe," "estimate," "potential, "predict," "project," "should," "would" and similar expressions and the negatives of those terms. These statements relate to future events or our financial performance and involve known and unknown risks, uncertainties, and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include those set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2021 as well as other documents filed by the Company from time to time thereafter with the Securities and Exchange Commission. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

For more information, contact:

Timber Pharmaceuticals, Inc.
John Koconis
Chairman and Chief Executive Officer
jkoconis@timberpharma.com

Investor Relations:
Stephanie Prince
PCG Advisory
(646) 863-6341
sprince@pcgadvisory.com

Media Relations:
Adam Daley
Berry & Company Public Relations
(212) 253-8881
adaley@berrypr.com

Ad15 Vehicles That Can Run Forever

These Cars Have No Problem Getting Past 250,000 Miles - Is Yours on the List?
The Time to Buy the Dip Is Fast Approaching — for One Country

(Bloomberg) -- Investors are looking beyond a looming global recession and they see one country – and its financial markets – emerging strongest on the other side.Most Read from BloombergNATO-China Tension Over Ukraine Flares at Conference in IcelandSecret Service Minimized Threats Before Jan. 6, Records ShowDeSantis Chief of Staff Planned Migrant Flights, Documents ShowUS stocks and bonds will lead the way out of the current wave of market turmoil, according to respondents in the latest MLIV Pu
2 Stock-Split Stocks That Could Double Your Money

Stock splits have been all the rage this year as several prominent companies have decided to go down this path to lower their share prices and boost the demand among retail investors at a time when the broader market has been in sell-off mode, but even this move hasn't given them reprieve on the stock market. Palo Alto Networks (NASDAQ: PANW), for instance, announced a three-for-one stock split on Aug. 22. Shares of the cybersecurity specialist shot up following the announcement, but they have lost momentum since thanks to the Federal Reserve's hawkish nature that has been weighing on the stock market this year.
Ad12 Foods You Can Eat a Lot of Without Getting Fat

List Of Healthy Foods You Can Eat Without Gaining Any Weight
China Stocks Fall as Xi Disappoints on Covid Policy and Property

(Bloomberg) -- Chinese traders hoping for signs of a shift away from Covid Zero and further support for the ailing property sector were disheartened by President Xi Jinping speech, spurring a decline in stocks. Most Read from BloombergNATO-China Tension Over Ukraine Flares at Conference in IcelandSecret Service Minimized Threats Before Jan. 6, Records ShowDeSantis Chief of Staff Planned Migrant Flights, Documents ShowThe benchmark CSI 300 Index slid as much as 0.9% Monday, after anticipations ah
Average Retirement Savings for Married Couples By Age

A recent study from the career experts Zety says that 40% of respondents fear retirement more than death. And almost nine in 10 responded that their biggest retirement fear is not having enough income. For married couples, planning retirement for two people can … Continue reading → The post Average Retirement Savings for Married Couples By Age appeared first on SmartAsset Blog.
Can Investors Trust AT&T's Juicy 7% Dividend?

Currently, AT&T sports a high 7.4% dividend yield, which means the company will pay an estimated 7.4% of its stock price to shareholders each year. This number constantly fluctuates because it is calculated using the annual dividend payout divided by the stock price. The yield rises if the dividend goes up and the stock price stays the same.
Bearish Bets: 3 Stocks You Should Think About Shorting This Week

Using technical analysis of the charts of those stocks, and, when appropriate, recent actions and grades from TheStreet's Quant Ratings, we zero in on three names. While we will not be weighing in with fundamental analysis, we hope this piece will give investors interested in stocks on the way down a good starting point to do further homework on the names. Plug Power Inc. recently was downgraded to Sell with a D+ rating by TheStreet's Quant Ratings.
Big Short Michael Burry Says Facebook Is In Big Trouble

The list of critics and detractors of Mark Zuckerberg is growing day by day. There is, of course, the financial community, analysts and investors, who are merciless about Meta Platforms , the entrepreneur's empire of social networks. Zuckerberg's strategy is what unites all these critics.
Goldman Sees Some Bargains in US But Finds S&P 500 Expensive

(Bloomberg) -- Goldman Sachs Group Inc. sees attractive opportunities emerging in US stocks even as the S&P 500 benchmark remains expensive versus its history and accounting for interest rates.Most Read from BloombergNATO-China Tension Over Ukraine Flares at Conference in IcelandSecret Service Minimized Threats Before Jan. 6, Records ShowDeSantis Chief of Staff Planned Migrant Flights, Documents ShowThe risk-reward for the S&P 500 Index remains unattractive but "the degree of valuation dispersio
AdGo Green with Green Financing

Building sustainable cities with green financing
AdMan Finds Tiny Creature In Backyard

You'll Never Believe What It Grew Into...
These 3 Stocks Underperformed the Market This Year. Is Now the Time to Buy?

Mortgage real estate investment trusts (REITs), which invest in debt, not property, have also been sold off as the Federal Reserve has raised interest rates. AGNC Investment (NASDAQ: AGNC) is a mortgage REIT that focuses primarily on investing in mortgage-backed securities (MBS) that are guaranteed by the U.S. government. AGNC Investment is probably the safest stock in the mortgage REIT space given that a potential recession would impact it less than most other mortgage REITs.
Why Occidental Petroleum Could Be Warren Buffett's Next Apple

At 92 and 86 years of age, respectively, Warren Buffett and Carl Icahn are two of the greatest living investors -- and both are still at it! In fact, these two seniors have been quite active this year, especially around oil giant Occidental Petroleum (NYSE: OXY). On the flip side, Warren Buffett has been buying Occidental shares hand over fist throughout the year, scooping up over 20% of the American oil driller.
AdFunny Images That Show How Small Things Are

These captivating photographs capture the unexpected scale of things in the physical world and elsewhere

vogelequirt.blogspot.com

Source: https://finance.yahoo.com/news/timber-pharmaceuticals-announces-notification-nyse-200500418.html

Deficient in Meeting the Exchange S Continued Listing Requirements

S&P Futures

Dow Futures

Nasdaq Futures

Russell 2000 Futures

Crude Oil

Gold

Silver

EUR/USD

10-Yr Bond

Vix

GBP/USD

USD/JPY

BTC-USD

CMC Crypto 200

FTSE 100

Nikkei 225

Timber Pharmaceuticals Announces Notification of NYSE American Continued Listing Deficiency

Ad15 Vehicles That Can Run Forever

The Time to Buy the Dip Is Fast Approaching — for One Country

2 Stock-Split Stocks That Could Double Your Money

Ad12 Foods You Can Eat a Lot of Without Getting Fat

China Stocks Fall as Xi Disappoints on Covid Policy and Property

Average Retirement Savings for Married Couples By Age

Can Investors Trust AT&T's Juicy 7% Dividend?

Bearish Bets: 3 Stocks You Should Think About Shorting This Week

Big Short Michael Burry Says Facebook Is In Big Trouble

Goldman Sees Some Bargains in US But Finds S&P 500 Expensive

AdGo Green with Green Financing

AdMan Finds Tiny Creature In Backyard

These 3 Stocks Underperformed the Market This Year. Is Now the Time to Buy?

Why Occidental Petroleum Could Be Warren Buffett's Next Apple

AdFunny Images That Show How Small Things Are

0 Response to "Deficient in Meeting the Exchange S Continued Listing Requirements"

Post a Comment

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel